![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Publisher: Adis International
ISSN: 1173-5503
Source: PharmacoEconomics and Outcomes News, Vol.1, Iss.500, 2006-01, pp. : 7-7
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Bimatoprost best bet for glaucoma in Europe
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 490, 2005-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Bimatoprost/timolol of value for glaucoma in Europe
Inpharma, Vol. 1, Iss. 1634, 2008-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Bimatoprost/timolol of value for glaucoma in Europe
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 551, 2008-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
An update on bimatoprost in glaucoma therapy
Expert Opinion on Pharmacotherapy, Vol. 3, Iss. 12, 2002-12 ,pp. :